Nami Therapeutics

Executive Summary

Nami Therapeutics is a privately held radiopharmaceutical company based in San Diego, founded in 2021. The company's proprietary technology leverages meticulously designed nanocarriers for precise, targeted delivery of therapeutics, supported by a robust global intellectual property portfolio. While still in the early stages of development, Nami is positioned at the intersection of nanotechnology and radiopharmaceuticals, aiming to improve the therapeutic index and reduce off-target effects of cancer treatments. The company's approach holds potential for addressing significant unmet needs in oncology, though clinical validation is pending. As a private entity with limited public disclosures, Nami's progress will depend on advancing its pipeline toward preclinical and clinical milestones, securing partnerships, and obtaining further financing.